(Q36119897)

12 August 2017

1 reference

title

Mood stabilization in the treatment of bipolar disorder: focus on quetiapine (English)

1 reference

12 August 2017

1 reference

Eduard Vieta

1

0 references

publication date

1 June 2005

1 reference

12 August 2017

published in

Human Psychopharmacology

1 reference

12 August 2017

volume

20

1 reference

12 August 2017

issue

4

1 reference

12 August 2017

page(s)

225-236

1 reference

Clinical Factors in Lithium Carbonate Prophylaxis Failure

12 August 2017

cites work

1 reference

Valproate in the treatment of acute mania. A placebo-controlled study

21 January 2018

1 reference

Depression during mania. Treatment response to lithium or divalproex.

21 January 2018

1 reference

A double-blind comparison of valproate and lithium in the treatment of acute mania

21 January 2018

1 reference

Practice guideline for the treatment of patients with bipolar disorder (revision)

21 January 2018

1 reference

7 January 2021

Mortality of patients with mood disorders: follow-up over 34-38 years

1 reference

7 January 2021

Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group

1 reference

7 January 2021

Maintenance treatment in bipolar disorder

1 reference

7 January 2021

Substance P and the neurokinins: novel peptide neurotransmitters in psychopharmacology

1 reference

7 January 2021

Clinical correlates of therapeutic response in bipolar disorder

1 reference

7 January 2021

Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group

1 reference

7 January 2021

A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group

1 reference

7 January 2021

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder

1 reference

7 January 2021

Safety and tolerability of lamotrigine for bipolar disorder

1 reference

7 January 2021

Quetiapine in bipolar disorder and cocaine dependence

1 reference

7 January 2021

A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

1 reference

7 January 2021

Current research on rapid cycling bipolar disorder and its treatment

1 reference

7 January 2021

Latest maintenance data on lamotrigine in bipolar disorder

1 reference

7 January 2021

Comparison of carbamazepine and lithium in the prophylaxis of bipolar disorders. A meta-analysis

1 reference

7 January 2021

A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania

1 reference

7 January 2021

Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder.

1 reference

7 January 2021

Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics

1 reference

7 January 2021

Diagnosing bipolar disorder and the effect of antidepressants: a naturalistic study.

1 reference

7 January 2021

Suicide risk in bipolar disorder during treatment with lithium and divalproex

1 reference

7 January 2021

Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology

1 reference

7 January 2021

"Mood-stabilizers: the archeology of the concept"--by M Harris, S Chandran, N Chakraborty and D Healy: a commentary

1 reference

7 January 2021

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression

1 reference

7 January 2021

The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania

1 reference

7 January 2021

Maintenance efficacy of divalproex in the prevention of bipolar depression

1 reference

7 January 2021

Mood-stabilizers: the archeology of the concept

1 reference

7 January 2021

Weight gain during treatment of bipolar I patients with olanzapine.

1 reference

7 January 2021

Screening for bipolar disorder in the community

1 reference

7 January 2021

Treatment of depressive symptoms with quetiapine

1 reference

7 January 2021

A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania

1 reference

7 January 2021

Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial

1 reference

7 January 2021

Outcome in the pharmacologic treatment of bipolar disorder

1 reference

7 January 2021

Redefining mood stabilization

1 reference

7 January 2021

What makes a drug a primary mood stabilizer?

1 reference

7 January 2021

A lithium clinic for bipolar patients: 2-year outcome of the first 148 patients

1 reference

7 January 2021

Does 'rebound mania' occur after stopping carbamazepine? A pilot study

1 reference

7 January 2021

Pharmacologic agents for the treatment of acute bipolar mania.

1 reference

7 January 2021

A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the quetiapine experience with safety and tolerability (QUEST) study

1 reference

7 January 2021

An overview of recent findings of the Stanley Foundation Bipolar Network (Part I).

1 reference

7 January 2021

National Institute of Mental Health Workshop Report on the Treatment of Bipolar Disorder

1 reference

7 January 2021

Bipolar mood disorder: practical strategies for acute and maintenance phase treatment

1 reference

7 January 2021

Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study

1 reference

7 January 2021

Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety

1 reference

7 January 2021

Quetiapine alone and added to a mood stabilizer for serious mood disorders

1 reference

7 January 2021

Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group

1 reference

7 January 2021

Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy

1 reference

7 January 2021

Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone

1 reference

7 January 2021

Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features.

1 reference

7 January 2021

Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group

1 reference

7 January 2021

Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study

1 reference

7 January 2021

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression

1 reference

7 January 2021

Long-term clinical effectiveness of lithium maintenance treatment in types I and II bipolar disorders

1 reference

7 January 2021

Do we need placebo control in maintenance studies in bipolar disorders?

1 reference

7 January 2021

Psychological interventions in bipolar disorder: From wishful thinking to an evidence-based approach

1 reference

7 January 2021

Quetiapine in the treatment of rapid cycling bipolar disorder.

1 reference

7 January 2021

Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance

1 reference

7 January 2021

An open longitudinal study of patients with bipolar rapid cycling treated with lithium or lamotrigine for mood stabilization

1 reference

7 January 2021

A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes.

1 reference

7 January 2021

Hyperprolactinaemia caused by antipsychotic drugs

1 reference

7 January 2021

Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial

1 reference

7 January 2021

Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania

1 reference

7 January 2021

Clinical predictors of acute response with quetiapine in psychotic mood disorders

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.689

1 reference

12 August 2017

1 reference